vs
BXP, Inc.(BXP)与Enovis CORP(ENOV)财务数据对比。点击上方公司名可切换其他公司
BXP, Inc.的季度营收约是Enovis CORP的1.6倍($872.1M vs $548.9M),BXP, Inc.净利率更高(15.3% vs -104.1%,领先119.3%),BXP, Inc.同比增速更快(0.8% vs -2.2%),过去两年Enovis CORP的营收复合增速更高(9.8% vs 1.3%)
BXP是美国头部商业地产投资信托企业,核心业务为持有、运营及开发A级高端写字楼资产,项目覆盖纽约、波士顿、旧金山等美国核心都市圈,服务企业、科技、专业服务等领域的多元租户。
Enovis是一家专注于骨科领域的医疗科技企业,其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿,目前在全球12个地点开展业务,拥有超过5000名员工,于纽约证券交易所上市,股票代码为ENOV。
BXP vs ENOV — 直观对比
营收规模更大
BXP
是对方的1.6倍
$548.9M
营收增速更快
BXP
高出3.0%
-2.2%
净利率更高
BXP
高出119.3%
-104.1%
两年增速更快
ENOV
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $872.1M | $548.9M |
| 净利润 | $133.0M | $-571.1M |
| 毛利率 | — | 59.9% |
| 营业利润率 | — | -101.7% |
| 净利率 | 15.3% | -104.1% |
| 营收同比 | 0.8% | -2.2% |
| 净利润同比 | 53.0% | 18.8% |
| 每股收益(稀释后) | $1.69 | $-9.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BXP
ENOV
| Q1 26 | $872.1M | — | ||
| Q4 25 | $877.1M | $548.9M | ||
| Q3 25 | $871.5M | $564.5M | ||
| Q2 25 | $868.5M | $558.8M | ||
| Q1 25 | $865.2M | — | ||
| Q4 24 | $858.6M | $561.0M | ||
| Q3 24 | $859.2M | $505.2M | ||
| Q2 24 | $850.5M | $525.2M |
净利润
BXP
ENOV
| Q1 26 | $133.0M | — | ||
| Q4 25 | $248.4M | $-571.1M | ||
| Q3 25 | $-121.7M | $-36.7M | ||
| Q2 25 | $89.0M | $-56.0M | ||
| Q1 25 | $61.2M | — | ||
| Q4 24 | $-228.9M | $-703.2M | ||
| Q3 24 | $83.6M | $-31.5M | ||
| Q2 24 | $79.6M | $-18.6M |
毛利率
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | 58.8% | 59.9% | ||
| Q3 25 | 59.3% | 59.3% | ||
| Q2 25 | 59.2% | 59.5% | ||
| Q1 25 | 59.2% | — | ||
| Q4 24 | 59.7% | 54.8% | ||
| Q3 24 | 59.5% | 56.7% | ||
| Q2 24 | 59.8% | 55.0% |
营业利润率
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | — | -101.7% | ||
| Q3 25 | — | -3.0% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -118.5% | ||
| Q3 24 | — | -6.3% | ||
| Q2 24 | — | -8.4% |
净利率
BXP
ENOV
| Q1 26 | 15.3% | — | ||
| Q4 25 | 28.3% | -104.1% | ||
| Q3 25 | -14.0% | -6.5% | ||
| Q2 25 | 10.2% | -10.0% | ||
| Q1 25 | 7.1% | — | ||
| Q4 24 | -26.7% | -125.4% | ||
| Q3 24 | 9.7% | -6.2% | ||
| Q2 24 | 9.4% | -3.5% |
每股收益(稀释后)
BXP
ENOV
| Q1 26 | $1.69 | — | ||
| Q4 25 | $1.56 | $-9.99 | ||
| Q3 25 | $-0.77 | $-0.64 | ||
| Q2 25 | $0.56 | $-0.98 | ||
| Q1 25 | $0.39 | — | ||
| Q4 24 | $-1.46 | $-12.69 | ||
| Q3 24 | $0.53 | $-0.58 | ||
| Q2 24 | $0.51 | $-0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | $33.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $7.7B | $2.0B |
| 总资产 | $25.1B | $4.4B |
| 负债/权益比越低杠杆越低 | — | 0.67× |
8季度趋势,按日历期对齐
现金及短期投资
BXP
ENOV
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | $33.6M | ||
| Q3 25 | $861.1M | $44.1M | ||
| Q2 25 | $447.0M | $38.5M | ||
| Q1 25 | $398.1M | — | ||
| Q4 24 | $1.3B | $48.2M | ||
| Q3 24 | $1.4B | $35.4M | ||
| Q2 24 | $685.4M | $35.0M |
总债务
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B |
股东权益
BXP
ENOV
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $2.0B | ||
| Q3 25 | $5.0B | $2.6B | ||
| Q2 25 | $5.3B | $2.6B | ||
| Q1 25 | $5.3B | — | ||
| Q4 24 | $5.4B | $2.6B | ||
| Q3 24 | $5.8B | $3.3B | ||
| Q2 24 | $5.8B | $3.3B |
总资产
BXP
ENOV
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $4.4B | ||
| Q3 25 | $26.0B | $5.0B | ||
| Q2 25 | $25.6B | $4.9B | ||
| Q1 25 | $25.4B | — | ||
| Q4 24 | $26.1B | $4.7B | ||
| Q3 24 | $26.4B | $5.6B | ||
| Q2 24 | $25.5B | $5.4B |
负债/权益比
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | — | 0.67× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.41× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $82.6M |
| 自由现金流经营现金流 - 资本支出 | — | $29.1M |
| 自由现金流率自由现金流/营收 | — | 5.3% |
| 资本支出强度资本支出/营收 | 1.5% | 9.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $22.8M |
8季度趋势,按日历期对齐
经营现金流
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | $407.8M | $82.6M | ||
| Q3 25 | $274.2M | $47.8M | ||
| Q2 25 | $353.1M | $-1.6M | ||
| Q1 25 | $210.0M | — | ||
| Q4 24 | $383.7M | $88.3M | ||
| Q3 24 | $286.1M | $53.6M | ||
| Q2 24 | $367.1M | $7.8M |
自由现金流
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | $362.7M | $29.1M | ||
| Q3 25 | $231.6M | $3.4M | ||
| Q2 25 | $281.5M | $-44.9M | ||
| Q1 25 | $152.6M | — | ||
| Q4 24 | $312.5M | $35.1M | ||
| Q3 24 | $234.5M | $2.4M | ||
| Q2 24 | $332.4M | $-31.6M |
自由现金流率
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | 41.4% | 5.3% | ||
| Q3 25 | 26.6% | 0.6% | ||
| Q2 25 | 32.4% | -8.0% | ||
| Q1 25 | 17.6% | — | ||
| Q4 24 | 36.4% | 6.3% | ||
| Q3 24 | 27.3% | 0.5% | ||
| Q2 24 | 39.1% | -6.0% |
资本支出强度
BXP
ENOV
| Q1 26 | 1.5% | — | ||
| Q4 25 | 5.1% | 9.7% | ||
| Q3 25 | 4.9% | 7.9% | ||
| Q2 25 | 8.2% | 7.7% | ||
| Q1 25 | 6.6% | — | ||
| Q4 24 | 8.3% | 9.5% | ||
| Q3 24 | 6.0% | 10.1% | ||
| Q2 24 | 4.1% | 7.5% |
现金转化率
BXP
ENOV
| Q1 26 | — | — | ||
| Q4 25 | 1.64× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.97× | — | ||
| Q1 25 | 3.43× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.42× | — | ||
| Q2 24 | 4.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |